Notice of Senior Executive Service Performance Review Board Membership, 71793-71794 [2012-29033]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 233 / Tuesday, December 4, 2012 / Notices
—Risk Assumed
—Leases
—Public Private Partnerships
—Technical Agenda, and
—Any other topics as needed.
Any interested person may attend the
meetings as an observer. Board
discussion and reviews are open to the
public. GAO Building security requires
advance notice of your attendance.
Please notify FASAB of your planned
attendance by calling 202–512–7350 at
least one day prior to the respective
meeting.
FOR FURTHER INFORMATION CONTACT:
PERSON TO CONTACT FOR INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
Shawn Woodhead Werth,
Secretary and Clerk of the Commission.
[FR Doc. 2012–29309 Filed 11–30–12; 11:15 am]
BILLING CODE 6715–01–P
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
mstockstill on DSK4VPTVN1PROD with
Wendy Payne, Executive Director, at
(202) 512–7350.
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
Authority: Federal Advisory Committee
§ 225.41 of the Board’s Regulation Y (12
Act, Public Law 92–463.
CFR 225.41) to acquire shares of a bank
Dated: November 28, 2012.
or bank holding company. The factors
Charles Jackson,
that are considered in acting on the
Federal Register Liaison Officer.
notices are set forth in paragraph 7 of
[FR Doc. 2012–29247 Filed 12–3–12; 8:45 am]
the Act (12 U.S.C. 1817(j)(7)).
BILLING CODE 1610–02–P
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
FEDERAL ELECTION COMMISSION
also will be available for inspection at
the offices of the Board of Governors.
Sunshine Act Meeting
Interested persons may express their
views in writing to the Reserve Bank
AGENCY: Federal Election Commission.
indicated for that notice or to the offices
DATE & TIME: Thursday, December 6,
of the Board of Governors. Comments
2012 at 10:00 a.m.
must be received not later than
PLACE: 999 E Street NW., Washington,
December 19, 2012.
DC (Ninth Floor).
A. Federal Reserve Bank of Richmond
STATUS: This meeting will be open to the (Adam M. Drimer, Assistant Vice
public.
President) 701 East Byrd Street,
ITEMS TO BE DISCUSSED:
Richmond, Virginia 23261–4528:
Correction and Approval of the Minutes
1. Paul Jerome Mitchell, Columbia,
for the Meeting of November 15, 2012 South Carolina; to acquire voting shares
Draft Advisory Opinion 2012–34:
of SCCB Financial Corporation, and
Freedom PAC and Friends of Mike H
thereby indirectly acquire voting shares
Draft Advisory Opinion 2012–35: Global of South Carolina Community Bank,
Transaction Services Group, Inc.
both in Columbia, South Carolina.
Draft Advisory Opinion 2012–36: Green
Board of Governors of the Federal Reserve
Party of Connecticut
System, November 29, 2012.
Draft Advisory Opinion 2012–37:
Margaret McCloskey Shanks,
Yamaha Motor Corporation, U.S.A.
Deputy Secretary of the Board.
Proposed Final Audit Report on
[FR Doc. 2012–29200 Filed 12–3–12; 8:45 am]
Minnesota Democratic-Farmer-Labor
BILLING CODE 6210–01–P
Party (A09–08)
Audit Division Recommendation
Memorandum on McCain-Palin 2008,
FEDERAL RESERVE SYSTEM
Inc. and McCain-Palin Compliance
Fund, Inc.
Formations of, Acquisitions by, and
Notice of Proposed Rulemaking: Limited
Mergers of Bank Holding Companies
Liability Partnerships
Management and Administrative
The companies listed in this notice
Matters
have applied to the Board for approval,
pursuant to the Bank Holding Company
Individuals who plan to attend and
Act of 1956 (12 U.S.C. 1841 et seq.)
require special assistance, such as sign
(BHC Act), Regulation Y (12 CFR part
language interpretation or other
225), and all other applicable statutes
reasonable accommodations, should
and regulations to become a bank
contact Shawn Woodhead Werth,
holding company and/or to acquire the
Secretary and Clerk, at (202) 694–1040,
assets or the ownership of, control of, or
at least 72 hours prior to the meeting
the power to vote shares of a bank or
date.
VerDate Mar<15>2010
17:31 Dec 03, 2012
Jkt 229001
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
71793
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than December 28,
2012.
A. Federal Reserve Bank of San
Francisco (Kenneth Binning, Vice
President, Applications and
Enforcement) 101 Market Street, San
Francisco, California 94105–1579:
1. First Northwest Bancorp, Port
Angeles, Washington; to become a bank
holding company upon the conversion
of First Federal Savings and Loan
Association of Port Angeles, Port
Angeles, Washington, from a mutual to
stock savings bank.
Board of Governors of the Federal Reserve
System, November 29, 2012.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2012–29201 Filed 12–3–12; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Senior Executive Service
Performance Review Board
Membership
The Agency for Healthcare Research
and Quality (AHRQ) announces the
appointment of members to the AHRQ
Senior Executive Service (SES)
Performance Review Board (PRB). This
action is being taken in accordance with
5 U.S.C. 4314(c)(4), which requires
notice of appointment of members to
performance review boards to be
published in the Federal Register.
E:\FR\FM\04DEN1.SGM
04DEN1
71794
Federal Register / Vol. 77, No. 233 / Tuesday, December 4, 2012 / Notices
Members of the PRB are appointed in
a manner that will ensure consistency,
stability and objectivity in the SES
performance appraisals. The function of
the PRB is to make recommendations to
the Director, AHRQ, relating to the
performance of senior executives in the
Agency.
The following persons will serve on
the AHRQ SES Performance Review
Board:
Irene Fraser
Stephen B. Cohen
William Munier
David Meyers
Michael Fitzmaurice
Phyllis Zucker
Mark Handelman
Jean Slutsky
For further information about the
AHRQ Performance Review Board,
contact Ms. Alison Reinheimer, Office
of Performance, Accountability,
Resources, and Technology, Agency for
Healthcare Research and Quality, 540
Gaither Road, Suite 4010, Rockville,
Maryland 20850.
Dated: November 26, 2012.
Carolyn M. Clancy,
Director, AHRQ.
[FR Doc. 2012–29033 Filed 12–3–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–13–0840]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
mstockstill on DSK4VPTVN1PROD with
Proposed Project
Formative Research and Tool
Development—(OMB # 0920–0840, Exp.
1/31/2013)—Revision—National Center
for HIV/AIDS, Viral Hepatitis, STD, TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
VerDate Mar<15>2010
17:31 Dec 03, 2012
Jkt 229001
Background and Brief Description
The Centers for Disease Control and
Prevention request approval for a
revision and a 3 year approval for the
previously approved Formative
Research and Tool Development. This
information collection request has been
revised to include one additional type of
formative research information
collection activity, additional detail
regarding the previously approved
categories of formative research, and
instrument testing for data collection
activities used to inform many aspects
of surveillance, communications, health
promotion, and research project
development for NCHHSTP’s 4 priority
diseases (HIV/AIDS, sexually
transmitted diseases/infections (STD/
STI), viral hepatitis, and tuberculosis
elimination. Formative research is the
basis for developing effective strategies
including communication channels, for
influencing behavior change. It helps
researchers identify and understand the
characteristics—interests, behaviors and
needs—of target populations that
influence their decisions and actions.
Formative research is integral in
developing programs as well as
improving existing and ongoing
programs. Formative research also looks
at the community in which a public
health intervention is being or will be
implemented and helps the project staff
understand the interests, attributes and
needs of different populations and
persons in that community. Formative
research is research that occurs before a
program is designed and implemented,
or while a program is being conducted.
Formative research is an integral part
of developing programs or adapting
programs that deal with the complexity
of behaviors, social context, cultural
identities, and health care that underlie
the epidemiology of HIV/AIDS, viral
hepatitis, STDs, and TB in the U.S.
CDC conducts formative research to
develop public-sensitive
communication messages and user
friendly tools prior to developing or
recommending interventions, or care.
Sometimes these studies are entirely
behavioral but most often they are
cycles of interviews and focus groups
designed to inform the development of
a product.
Products from these formative
research studies will be used for
prevention of HIV/AIDS, Sexually
Transmitted Infections (STI), viral
Hepatitis, and Tuberculosis. Findings
from these studies may also be
presented as evidence to diseasespecific National Advisory Committees,
to support revisions to recommended
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
prevention and intervention methods, as
well as new recommendations.
Much of CDC’s health communication
takes place within campaigns that have
fairly lengthy planning periods—
timeframes that accommodate the
standard Federal process for approving
data collections. Short term qualitative
interviewing and cognitive research
techniques have previously proven
invaluable in the development of
scientifically valid and populationappropriate methods, interventions, and
instruments.
This request includes studies
investigating the utility and
acceptability of proposed sampling and
recruitment methods, intervention
contents and delivery, questionnaire
domains, individual questions, and
interactions with project staff or
electronic data collection equipment.
These activities will also provide
information about how respondents
answer questions and ways in which
question response bias and error can be
reduced.
This request also includes collection
of information from public health
programs to assess needs related to
initiation of a new program activity or
expansion or changes in scope or
implementation of existing program
activities to adapt them to current
needs. The information collected will be
used to advise programs and provide
capacity-building assistance tailored to
identified needs.
Overall, these development activities
are intended to provide information that
will increase the success of the
surveillance or research projects
through increasing response rates and
decreasing response error, thereby
decreasing future data collection burden
to the public. The studies that will be
covered under this request will include
one or more of the following
investigational modalities: (1) structured
and qualitative interviewing for
surveillance, research, interventions and
material development, (2) cognitive
interviewing for development of specific
data collection instruments, (3)
methodological research (4) usability
testing of technology-based instruments
and materials, (5) field testing of new
methodologies and materials, (6)
investigation of mental models for
health decision-making, to inform
health communication messages, and (7)
organizational needs assessment to
support development of capacity.
Respondents who will participate in
individual and group interviews
(qualitative, cognitive, and computer
assisted development activities) are
selected purposively from those who
respond to recruitment advertisements.
E:\FR\FM\04DEN1.SGM
04DEN1
]]>Agencies
[Federal Register Volume 77, Number 233 (Tuesday, December 4, 2012)]
[Notices]
[Pages 71793-71794]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-29033]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Senior Executive Service Performance Review Board
Membership
The Agency for Healthcare Research and Quality (AHRQ) announces the
appointment of members to the AHRQ Senior Executive Service (SES)
Performance Review Board (PRB). This action is being taken in
accordance with 5 U.S.C. 4314(c)(4), which requires notice of
appointment of members to performance review boards to be published in
the Federal Register.
[[Page 71794]]
Members of the PRB are appointed in a manner that will ensure
consistency, stability and objectivity in the SES performance
appraisals. The function of the PRB is to make recommendations to the
Director, AHRQ, relating to the performance of senior executives in the
Agency.
The following persons will serve on the AHRQ SES Performance Review
Board:
Irene Fraser
Stephen B. Cohen
William Munier
David Meyers
Michael Fitzmaurice
Phyllis Zucker
Mark Handelman
Jean Slutsky
For further information about the AHRQ Performance Review Board,
contact Ms. Alison Reinheimer, Office of Performance, Accountability,
Resources, and Technology, Agency for Healthcare Research and Quality,
540 Gaither Road, Suite 4010, Rockville, Maryland 20850.
Dated: November 26, 2012.
Carolyn M. Clancy,
Director, AHRQ.
[FR Doc. 2012-29033 Filed 12-3-12; 8:45 am]
BILLING CODE 4160-90-M
